Loading company…
Stemgent provides tools and resources for stem cell research and cellular reprogramming.
Stemgent provides tools and resources for stem cell research, with a focus on cellular reprogramming and induced pluripotent stem cells. Its offerings include cell lines, small molecules, antibodies, human iPSC-derived cells, collagen products and perfusion plates. The company was founded in 2007 by Ian Ratcliffe and is based in Massachusetts, US. In August 2012, it raised USD 11.3 million from undisclosed investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in